College of Medicine UVM Fletcher Allen Events Make A Gift Site Map

Pathology
Pathology

"To measure is to know."
Lord Kelvin 1824-1907

Search
Pathology Home
Department Vision
Faculty & Staff
Education
Research
Recent Publications
Conferences
Employment Opportunities
Patient Care
Contact Us


Brooke T. Mossman, Ph.D.
 


Education

MS - University of Vermont, Physiology & Biophysics, 1970
PhD - University of Vermont, Cell Biology, 1977


Expertise

Environmental toxicology, epithelial cell differentiation, chemical and physical carcinogenesis and cell injury, pulmonary fibrosis, oxygen free radicals, molecular biology of antioxidant enzymes in lung, cell signaling


Academic Appointments

1995 - Director, Environmental Pathology Program, University of Vermont
1995 - 1998 Program Leader, Cell Signaling and Growth Control Research Program, Vermont Cancer Center
1992 - Professor, Department of Pathology, University of Vermont
1989 - Adjunct Faculty Member, In Vitro Cell Biology and Biotechnology Program, State University of New York, Plattsburgh, NY
1984 - 1992 Associate Professor, Department of Pathology, University of Vermont
1984 - 1988 Chair, Cell and Molecular Biology Program, University of Vermont
1980 - 1983 Assistant Professor, Department of Pathology, University of Vermont
1978 - 1980 Research Assistant Professor, Department of Pathology, University of Vermont
1975 - 1977 Research Associate, Department of Pathology, University of Vermont
1973 - 1974 Research Assistant, Department of Pathology, University of Vermont
1970 - 1973 Research Assistant, Institute of Environmental Medicine, New York Univ, Sterling Forest, NY
1968 - 1970 Research Assistant, Department of Obstetrics & Gynecology, University of Vermont
1968 - 1970 Graduate Student, Physiology and Biophysics, University of Vermont


Publications

Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Gell J, Pass H, Carbone M, Testa J, Altomare DA, Heintz N, and Mossman BT: HGF mediates cell proliferation on human mesothelioma cells through a PI3K/MEK5/ Fra-1 pathway. Am J Respir Cell Mol Biol 38:209-217, 2008.
Blumen SR, Cheng K, MacPherson MB, Ramos-Nino ME, James TA, Taatjes DJ, Landry CC, and Mossman BT: Acid-prepared mesoporous spheres (APMS) increase efficacy of doxorubicin transfer and toxicity in human mesothelioma cells. (Submitted).
Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, and Weiss DJ: Decreased asbestos-induced lung inflammation and fibrosis following irradiation and bone marrow transplantation. Am J Respir Cell Mol Biol 38:16-25, 2008.
Haegens A, Vernooy JHJ, Heeringa P, van Suylen R-J, Steele C, Mossman BT, and Wouters EFM: Myeloperoxidase deficiency attenuates LPS induced acute lung inflammation and injury. Eur Respir J  31:252-260, 2008.
Mossman BT: Fiber and Particle Carcinogenesis. In: The Molecular Basis of Human Cancer (WB Coleman and GJ Tsongalis eds.), Humana Press, Inc., Totowa, NJ, 2nd Ed., (In progress).
Buder-Hoffmann SA, Shukla A, Barrett TF, Lounsbury KM, and Mossman BT: A PKCd-dependent PKD pathway modulates ERK1/2 and JNK1/2 phosphorylation and Bim-induced apoptosis by asbestos. Am J Pathol (In preparation).
Swain WA, Barrett TF, MacPherson MB, Gell JJ, O’Byrne KJ, Houghton CE, Ramos-Nino ME, Testa JR, Faux SP, and Mossman BT: Asbestos activates EGFR-dependent PI3K/AKT and ERK1/2 survival pathways in human mesothelial cells that trigger a JNK-mediated death pathway. Cancer Res (Submitted).
Fukagawa NK, Li M, Sabo-Attwood T, Timblin CR, Butnor KJ, Gagne J, Steele C, Taatjes DJ, Huber S, and Mossman BT: Airborne pathogenic particulates exacerbate atherosclerosis in ApoE-deficient mice via CD4+ T cells (Submitted).
Dostert C, Pétrilli V, Van Bruggen R, Steele C, Mossman BT, and Tschopp J: Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science Apr 10 [Epub ahead of print], 2008.
Haegens A, Vernooy JHJ, Cloots RHE, Kelders MCJM, Drummen NEA, Xanthoulea S, Bast A, Fehrenbach H, Poynter ME, Mossman BT, and Wouters EFM: Myeloperoxidase attenuates LPS-induced airspace enlargement. Am J Respir Cell Mol Biol (Submitted).
Heintz NH and Mossman BT: Molecular responses to asbestos: induction of cell proliferation and apoptosis via modulation of redox-dependent signaling pathways. In: Asbestos and Its Diseases, JE Craighead and A Gibbs, eds.), Oxford University Press, Oxford, UK (In Press).
Blumen SR, Cheng K, Hillegass J, MacPherson MB, Alexeeva V, Ramos-Nino ME, Shukla A, James TA, Weiss DJ, Taatjes DJ, Landry CC, and Mossman BT: Delivery of doxorubicin by acid-prepared mespoprous spheres increases expression of DNA damage and response genes and human mesothelioma cell death. Mol Cancer Ther (Submitted).
Ramos-Nino ME, Blumen SR, Sabo-Attwood T, Gell J, Pass H, Carbone M, Testa J, Altomare DA, Heintz N, and Mossman BT: HGF mediates cell proliferation on human mesothelioma cells through a PI3K/MEK5/ Fra-1 pathway. Am J Respir Cell Mol Biol 38:209-217, 2008.
Barlow CA, Kitiphongspattana K, Siddiqui N, Roe MW, Mossman, BT, and Lounsbury KM: Protein kinase A-mediated CREB phosphorylation is an oxidant-induced survival pathway in alveolar type II cells. Apoptosis 13:681-692, 2008.
O’Hara KA, MacPherson MB, Manning NA, Klei LR, Mossman BT, and Barchowsky A: Persistent co-localization of activates Src family kinases and mitogen-activated protein kinases in airway epithelial cells following in vivo exposure to chromium (VI). Toxicol Sci (In revision).
Mossman BT: Assessing nanotixicity by detecting toxicity to cells. In: Wiley Interdisciplinary Reviews: Nanomedicine (ed.) John Wiley & Sons, Inc., Hoboken NJ, (In progress).
Mossman BT, Borm PJ, Castranova V, Costa DL, Donaldson K, and Kleeberger SR: Meeting proceedings: mechanisms of action of inhaled fibers, particles, and nanoparticles in lung and cardiovascular diseases. (On-line journal) .
Janssen-Heininger YMW, Mossman, BT, Heintz NH, Forman H, Kalyanaraman B, Stamler JS, and van der Vliet A: Redox regulation of signal transduction: principles, pitfalls, and promises (Invited Review). Free Radic Biol Med. (In Press), 2008.
Manning CB, Sabo-Attwood T, Robledo RF, Rincon M, Shukla A, Ramos-Nino M, Vacek P, Hemenway D, Taatjes DJ, and Mossman BT: Transgenic interruption of the extracellular signal-regulated kinase (ERK1/2) cascade in vivo inhibits proliferation and alters differentiation of bronchiolar epithelium after asbestos injury, Am J Pathol (In Revision).
Stevens JP, Zahardis J, MacPherson M, Mossman BT, and Petrucci GA: A new method for quantifiable and controlled dosage of particulate matter for in vitro studies: the Electrostatic Particulate Dosage and Exposure System (EPDExS). In Vitro Toxicol (In preparation).
Blumen SR and Mossman BT: Chemical and environmental agents in the pathogenesis of lung cancers and mesothelioma. In: Molecular Pathology of Lung Disease, (P Cagle, DS Zander, J Jagirdar, R Barrios, A Haque, and H Popper, eds.), Springer-Verlag, New York, NY (In Press).
Cheng K, Blumen SR. MacPherson MB, Weiss DJ, JAme TA, Mossman BT, and Landry CC: Targeted uptake of bifunctionality modified nanoporous particles by malignant mesothelioma cells. Nature Nanomed (In preparation).
Shukla A, MacPherson MB, Hillegass J, Ramos-Nino ME, Alexeeva V, Vacek PM, Bond JP, and Mossman BT: Increased alterations in gene expression in human mesothelial cells correlate with mineral toxicity and pathogenicity. Am J Respir Cell Mol Biol (Submitted).
Barlow C, Shukla A, Mossman B, and Lounsbury K: Asbestos-mediated CREB phosphorylation is regulated by protein kinase A and extracellular signal regulated kinases 1/2. Am J Physiol: Lung Cell Mol Physiol 292:L1361-L1369, 2007.
Mossman, BT, Shukla A, and Fukagawa, NK: A highlight on “Oxidative stress and lipid mediators induced in alveolar macrophages by ultrafine particles” Free Radic Biol Med 43:504–505, 2007

Blumen SR, Cheng K, Ramos-Nino ME, Taatjes DJ, Weiss DJ, Landry CC, and Mossman BT: Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells. Am J Respir Cell Mol Biol 36:333-342, 2007.

Ramos-Nino ME, Blumen SR, and Mossman BT: Fra-1 governs cell migration via modulation of CD44 expression in human mesotheliomas. (On-line journal) http://www.molecular-cancer.com/content/6/1/81 Mol Cancer 6:81, 2007.

Haegens A, Barrett TF, Gell J, Shukla A, MacPherson M, Vacek P, Poynter ME, Butnor KJ, Janssen-Heininger YM, Steele C, and Mossman BT: Airway epithelial NF-?B activation modulates asbestos-induced inflammation and mucin production in vivo. J Immunol 178:1800-1808, 2007.

Barlow C, Shukla A, Mossman B, and Lounsbury K: Asbestos-mediated CREB phosphorylation is regulated by protein kinase A and extracellular signal regulated kinases 1/2. Am J Physiol: Lung Cell Mol Physiol 292:L1361-L1369, 2007.
Shukla A, Lounsbury KM, Barrett TF, Gell J, Rincón M, Butnor KJ, Taatjes DJ, Davis GS, Vacek P, Nakayama KI, Nakayama K, Steele C, and Mossman BT: Asbestos-induced peribronchiolar cell proliferation and cytokine production are attenuated in lungs of protein kinase C-delta knockout mice. Am J Pathol 170:140-151, 2007.
Blumen SR, Cheng K, Ramos-Nino ME, Taatjes DJ, Weiss DJ, Landry CC, and Mossman BT: Unique uptake of acid-prepared mesoporous spheres by lung epithelial and mesothelioma cells. Am J Respir Cell Mol Biol 36:333-342, 2007.
Mossman BT: Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol Oct 11 [Epub ahead of print], 2007.
Levis JE and Mossman BT: Cell signaling pathways elicited by particulates. In: Particle Toxicology, (K Donaldson and P Borm, eds.), CRC Press, Inc., Boca Raton, FL, 197-209, 2007.
 
Full List of Dr. Mossman's Publications on PubMed

   
 
College Home |  UVM |  Fletcher Allen |  College Events |  Make A Gift |  Site Map
  © 2010 The University of Vermont